These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24091766)

  • 1. GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies.
    Hosoi Y; Suzuki-Sakao M; Terada T; Konishi T; Ouchi Y; Miyajima H; Kono S
    J Neurol; 2013 Dec; 260(12):3086-92. PubMed ID: 24091766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia.
    Takenoshita H; Shizuka-Ikeda M; Mitoma H; Song S; Harigaya Y; Igeta Y; Yaguchi M; Ishida K; Shoji M; Tanaka M; Mizusawa H; Okamoto K
    J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):386-9. PubMed ID: 11181864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies.
    Ishida K; Mitoma H; Mizusawa H
    J Neurol Sci; 2008 Aug; 271(1-2):186-90. PubMed ID: 18534624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.
    Nanri K; Okita M; Takeguchi M; Taguchi T; Ishiko T; Saito H; Otsuka T; Mitoma H; Koizumi K
    Intern Med; 2009; 48(10):783-90. PubMed ID: 19443972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
    Planche V; Marques A; Ulla M; Ruivard M; Durif F
    Cerebellum; 2014 Jun; 13(3):318-22. PubMed ID: 24218114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-GAD Antibodies and the Cerebellum: Where Do We Stand?
    Manto M; Mitoma H; Hampe CS
    Cerebellum; 2019 Apr; 18(2):153-156. PubMed ID: 30343467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
    Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
    Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
    Baizabal-Carvallo JF
    J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.
    Georgieva Z; Parton M
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24419643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies.
    Vianello M; Tavolato B; Armani M; Giometto B
    Cerebellum; 2003; 2(1):77-9. PubMed ID: 12882238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
    Vale TC; Pedroso JL; Alquéres RA; Dutra LA; Barsottini OG
    J Neurol Sci; 2015 Dec; 359(1-2):21-3. PubMed ID: 26671081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-GAD antibodies and periodic alternating nystagmus.
    Tilikete C; Vighetto A; Trouillas P; Honnorat J
    Arch Neurol; 2005 Aug; 62(8):1300-3. PubMed ID: 16087772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual impairment of GABAA- and GABAB-receptor-mediated synaptic responses by autoantibodies to glutamic acid decarboxylase.
    Mitoma H; Ishida K; Shizuka-Ikeda M; Mizusawa H
    J Neurol Sci; 2003 Apr; 208(1-2):51-6. PubMed ID: 12639725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias.
    Mitoma H; Manto M; Hampe CS
    J Immunol Res; 2017; 2017():2913297. PubMed ID: 28386570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
    Abele M; Weller M; Mescheriakov S; Bürk K; Dichgans J; Klockgether T
    Neurology; 1999 Mar; 52(4):857-9. PubMed ID: 10078741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An altered GABA-A receptor function in spinocerebellar ataxia type 6 and familial hemiplegic migraine type 1 associated with the CACNA1A gene mutation.
    Kono S; Terada T; Ouchi Y; Miyajima H
    BBA Clin; 2014 Dec; 2():56-61. PubMed ID: 26675662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase.
    Ishida K; Mitoma H; Song SY; Uchihara T; Inaba A; Eguchi S; Kobayashi T; Mizusawa H
    Ann Neurol; 1999 Aug; 46(2):263-7. PubMed ID: 10443895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
    Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
    Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of oral corticosteroids therapy in anti-glutamic acid decarboxylase antibodies cerebellar ataxia.
    di Biase L; Assenza G; Iorio R; Melgari JM; Salomone G; Marano M; Muda AO; Di Lazzaro V
    Parkinsonism Relat Disord; 2016 Sep; 30():78-80. PubMed ID: 27236207
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
    Honnorat J; Saiz A; Giometto B; Vincent A; Brieva L; de Andres C; Maestre J; Fabien N; Vighetto A; Casamitjana R; Thivolet C; Tavolato B; Antoine J; Trouillas P; Graus F
    Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.